Researchers from a southeastern Spanish University have announced the discovery of a molecule that could be used to combat the effects of Zika virus.
According to a statement released by the San Antonio Catholic University of Murcia on 22 July 2017, researchers from its Bioinformatics and High-Performance Computing research group have discovered that a compound called ‘novobiocin’ that was previously used as an anti-biotic countered the symptoms of the mosquito-borne disease.
"It's a drug that had been withdrawn from the market because it had lost its potency as an antibiotic, but we know it can be administered to humans," said Josï¿½ Pedro Cerï¿½n, a member of the research team.
• The molecular structure of the proteins involved in the Zika virus' replication process was first described only a year ago.
• Researchers focused on an antibiotic that had been previously prescribed to fight off nosocomial infections, the infections that are acquired inside a hospital.
• The teams of both universities have now patented the molecule as an anti-Zika treatment.
• The compound, known as ‘novobiocin’ had phenomenal results when given to mice with a 100 per cent cure rate.
• The only remaining task is to figure out the correct proportion of dose needed to cure humans with a 100 per cent success rate.
The research team comprising four members including Cerï¿½n, De Haan, Horacio Pï¿½rez Sï¿½nchez and Jorge de la Peï¿½a-Garcï¿½a, make up the only Spanish team to have published papers in the field of anti-Zika drugs.
About Zika Virus
• The Zika virus disease is caused by a virus transmitted primarily by Aedes mosquitoes.
• The symptoms experienced by those affected include mild fever, skin rash, conjunctivitis, muscle and joint pain, malaise or a headache. The duration of these symptoms is normally for 2-7 days.
• The virus was first identified in Uganda in 1947 in monkeys through a network that monitored yellow fever.
• It was later identified in humans in 1952 in Uganda and the United Republic of Tanzania.
• Outbreaks of the disease have been recorded in Africa, the Americas, Asia and the Pacific.
• It saw a swift expansion between early 2015 and January 2016 throughout South America and the Caribbean.
• It was around the same time that factors such as tropical climates and insufficient mosquito-population control led the World Health Organization to term the disease as an epidemic and a global emergency.
Parliament passes Insolvency and Bankruptcy Code (Second Amendment) Bill, 2018
Assam-NRC Draft can’t be basis of any action by any authority: SC
Government to soon introduce bill proposing death penalty for mob lynching
Ministry of Shipping issues new guidelines for improving treasury investment for Major Ports